Daiichi Sankyo
Mitchell LeSueur has a diverse work experience in supply planning, logistics, and operations. Mitchell is currently working at Daiichi Sankyo, Inc. as a Project Lead, overseeing global clinical supply operations. Prior to this, they worked for Glenmark Pharmaceuticals as a Senior Associate, handling clinical supply planning and logistics. At Glenmark, Mitchell also served as an Associate Manager in supply chain operations and logistics, where they were involved in IT development and compliance tasks for the US distribution center. Mitchell began their career at Taro Pharmaceuticals as a Supply Chain Intern, where they gained experience in inventory planning and reconciliation. Mitchell has also worked in the food industry as a waiter at Wasabi Grill. In addition, they have internship experience in materials management and administrative support at Progenitor Cell Therapy.
Mitchell LeSueur attended Syracuse University - Martin J. Whitman School of Management from 2012 to 2016, earning a Bachelor of Science (B.S.) degree with a double major in Supply Chain Management and Marketing. In 2014, they participated in the Syracuse University Study Abroad - Summer Session at the Instituto Internacional en España in Madrid, Spain. Mitchell also completed the Project Advance (SUPA) program at Syracuse University from 2011 to 2012. Prior to attending college, they graduated from Clarkstown High School North in New City, NY in 2012, receiving an Advanced Regents Diploma / International Baccalaureate (IB). In 2019, Mitchell obtained a Certified Supply Chain Professional (CSCP) certification from APICS.
This person is not in the org chart
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.